Meeder Asset Management Inc Verrica Pharmaceuticals Inc. Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$9.55 - $13.96 $39,632 - $57,934	-4,150 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$9.77 - $15.33 $40,545 - $63,619	4,150 New	4,150 $47,000
Q4 2020 Feb 09, 2021	SELL	$7.41 - $12.63 $4,690 - $7,994	-633 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$6.16 - $10.3 $351 - $587	-57 Reduced 8.26%	633 $5,000
Q2 2020 Aug 11, 2020	SELL	$9.02 - $15.12 $29,143 - $48,852	-3,231 Reduced 82.4%	690 $8,000
Q1 2020 May 15, 2020	SELL	$7.14 - $16.86 $2,734 - $6,457	-383 Reduced 8.9%	3,921 $42,000
Q4 2019 Feb 13, 2020	BUY	$13.08 - $17.43 $56,296 - $75,018	4,304 New	4,304 $69,000

14.2M

9.9K

6.5K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.